EGI
ORGO icon

EAM Global Investors’s Organogenesis Holdings ORGO Stock Holding History

EAM Global Investors’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-189,712
Closed -$3.46M – 187
2021
Q1 		$3.46M Buy
+189,712
New +$2.57M 0.96% 18

Other funds holding ORGO

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NMIMC
Northwestern Mutual Investment Management Company Milwaukee, Wisconsin $6.6B AUM 19.75% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EAM Global Investors's ORGO Position: Q2 2021 in Review

EAM Global Investors sold out of Organogenesis Holdings (ORGO) in Q2 2021, closing a stake of 189,712 shares — an estimated $3.46M sold.

EAM Global Investors first reported a position in ORGO in Q1 2021 and held it in 1 quarter. The position peaked at $3.46M in Q1 2021. 142 funds tracked by Wall St. Rank hold ORGO as of Q2 2021.

  • EAM Global Investors reported no remaining Organogenesis Holdings position as of Q2 2021 after selling out during the quarter.
  • EAM Global Investors sold 189,712 Organogenesis Holdings shares in Q2 2021, an estimated $3.46M.
  • EAM Global Investors first reported a position in Organogenesis Holdings in Q1 2021 and held it in 1 quarter.
  • EAM Global Investors's Organogenesis Holdings position peaked at $3.46M in Q1 2021.
  • 142 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2021.

Based on EAM Global Investors's 13F filing for Q2 2021, filed 13 Aug 2021.